GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ChitogenX Inc (XCNQ:CHGX) » Definitions » EV-to-EBITDA

ChitogenX (XCNQ:CHGX) EV-to-EBITDA : -6.94 (As of May. 22, 2025)


View and export this data going back to 2017. Start your Free Trial

What is ChitogenX EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, ChitogenX's enterprise value is C$5.02 Mil. ChitogenX's EBITDA for the trailing twelve months (TTM) ended in Oct. 2024 was C$-0.72 Mil. Therefore, ChitogenX's EV-to-EBITDA for today is -6.94.

The historical rank and industry rank for ChitogenX's EV-to-EBITDA or its related term are showing as below:

XCNQ:CHGX' s EV-to-EBITDA Range Over the Past 10 Years
Min: -6.94   Med: 0   Max: 0
Current: -6.94

XCNQ:CHGX's EV-to-EBITDA is ranked worse than
100% of 495 companies
in the Biotechnology industry
Industry Median: 8.09 vs XCNQ:CHGX: -6.94

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-05-22), ChitogenX's stock price is C$0.01. ChitogenX's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2024 was C$-0.022. Therefore, ChitogenX's PE Ratio (TTM) for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


ChitogenX EV-to-EBITDA Historical Data

The historical data trend for ChitogenX's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ChitogenX EV-to-EBITDA Chart

ChitogenX Annual Data
Trend Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only -4.27 -8.27 -4.69 -3.85 -16.28

ChitogenX Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.67 -16.28 -6.96 -6.15 -6.36

Competitive Comparison of ChitogenX's EV-to-EBITDA

For the Biotechnology subindustry, ChitogenX's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ChitogenX's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ChitogenX's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where ChitogenX's EV-to-EBITDA falls into.


;
;

ChitogenX EV-to-EBITDA Calculation

ChitogenX's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=5.017/-0.723
=-6.94

ChitogenX's current Enterprise Value is C$5.02 Mil.
ChitogenX's EBITDA for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.72 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ChitogenX  (XCNQ:CHGX) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

ChitogenX's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.01/-0.022
=At Loss

ChitogenX's share price for today is C$0.01.
ChitogenX's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.022.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


ChitogenX EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of ChitogenX's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


ChitogenX Business Description

Traded in Other Exchanges
Address
16667 Hymus Boulevard, Kirkland, Montreal, QC, CAN, H9H 4R9
ChitogenX Inc is a clinical-stage biotech company. It operates in one segment, which is the development of novel therapeutic soft tissue repair technologies.
Executives
Luc Mainville Senior Officer

ChitogenX Headlines

From GuruFocus

Top 5 3rd Quarter Trades of Colorado Capital Management, Inc.

By GuruFocus Research GuruFocus Editor 10-19-2022

IMPACTfolio, LLC Buys 3, Sells 2 in 2nd Quarter

By GuruFocus Research GuruFocus Editor 07-06-2022

Top 5 4th Quarter Trades of Colorado Capital Management, Inc.

By GuruFocus Research GuruFocus Editor 01-18-2023